The ninth edition of the new coronary treatment protocol is the Novel Coronavirus Pneumonia Treatment Protocol (Trial Ninth Edition), which was released on March 15, 2022, and it has undergone a number of changes from the eighth edition, as follows: 1. admission criteria: (1) Antigen testing has been added to nucleic acid testing, but antigen testing is currently only used as a supplement to improve early detection, and the new version of the Diagnostic and Treatment Program does not include it as a basis for confirming the diagnosis. (2) For light cases, centralized isolation management is adopted. Symptomatic treatment and condition monitoring during isolation management are sufficient, and if the condition worsens, the case will be transferred to a designated hospital for treatment. 2. Treatment: Recommend two specific anti-new coronavirus drugs, PF-07321332/ritonavir tablets (Paxlovid) and domestically produced monoclonal antibodies (Ambavizumab/Romivizumab injection). 3. Criteria for release from isolation management and discharge: (1) The criteria for release from quarantine management and discharge have been changed to “Two consecutive novel coronavirus nucleic acid tests with CT values of N gene and ORF gene both ≥35 (fluorescent quantitative PCR method, the cut-off value is 40, and the sampling time interval is at least 24 hours), or two consecutive novel coronavirus nucleic acid tests negative (fluorescent quantitative PCR method, the cut-off value is lower than 35, and the sampling time interval is at least 24 hours)”. 35, with a sampling interval of at least 24 hours).” (2) After release from isolation management or discharge from the hospital, the phrase “14 days of isolation management and health monitoring” has been revised to read “7 days of continued home health monitoring”. 4. New: Added contents on Chinese medicine treatment, including acupuncture treatment and Chinese medicine treatment for children. If there is a suspicion of novel coronavirus infection, report it promptly and follow the arrangements of the local CDC and community staff. Tip: In this article, “new coronary pneumonia and new coronary virus pneumonia” were renamed to “new coronary virus infection” on December 26, 2022, as announced by the National Health Commission.